These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8518220)

  • 1. Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data Center.
    Vermorken JB; Gundersen S; Clavel M; Smyth JF; Dodion P; Renard J; Kaye SB
    Ann Oncol; 1993 Apr; 4(4):303-6. PubMed ID: 8518220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer.
    de Wit R; Tesselaar M; Kok TC; Seynaeve C; Rodenburg CJ; Verweij J; Helle PA; Stoter G
    Eur J Cancer; 1991; 27(11):1383-5. PubMed ID: 1835851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
    McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
    J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
    Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
    J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study.
    Weiss G; Green S; Alberts DS; Thigpen JT; Hines HE; Hanson K; Pierce HI; Baker LH; Goodwin JW
    Eur J Cancer; 1991; 27(2):135-8. PubMed ID: 1827275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
    Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
    Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.
    Meisner DJ; Ginsberg S; Ditch A; Louie A; Newman N; Comis R; Poiesz B
    Am J Clin Oncol; 1989 Apr; 12(2):129-31. PubMed ID: 2705402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial of iproplatin (cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV, CHIP) in patients with advanced breast cancer.
    Casper ES; Smart TC; Hakes TB; Ochoa M; Kaufman RJ
    Invest New Drugs; 1988 Jun; 6(2):87-91. PubMed ID: 3049433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).
    van Glabbeke M; Renard J; Pinedo HM; Cavalli F; Vermorken J; Sessa C; Abele R; Clavel M; Monfardini S
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):255-62. PubMed ID: 3281842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I--preliminary phase II trial of iproplatin, a cisplatin analogue.
    Paolozzi FP; Gaver R; Poiesz BJ; Louie A; DiFino S; Comis RL; Newman N; Ginsberg S
    Invest New Drugs; 1988 Sep; 6(3):199-206. PubMed ID: 3192385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group study.
    Alberts D; Mason N; Surwit E; Weiner S; Hammond N; Deppe G
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():83-92. PubMed ID: 3910225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.
    Anderson H; Wagstaff J; Crowther D; Swindell R; Lind MJ; McGregor J; Timms MS; Brown D; Palmer P
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1471-9. PubMed ID: 3053207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
    Hecquet B; Caty A; Fournier C; Lefebvre JL; Adenis L
    Bull Cancer; 1987; 74(4):433-6. PubMed ID: 3311237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of carboplatin versus iproplatin in untreated advanced ovarian cancer.
    Trask C; Silverstone A; Ash CM; Earl H; Irwin C; Bakker A; Tobias JS; Souhami RL
    J Clin Oncol; 1991 Jul; 9(7):1131-7. PubMed ID: 2045855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)].
    Chawla SP; Yap BS; Tenney DM; Bodey GP; Benjamin RS
    Invest New Drugs; 1988 Dec; 6(4):311-7. PubMed ID: 3229943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of iproplatin in advanced ovarian carcinoma.
    Sessa C; Vermorken J; Renard J; Kaye S; Smith D; ten Bokkel Huinink W; Cavalli F; Pinedo H
    J Clin Oncol; 1988 Jan; 6(1):98-105. PubMed ID: 3335895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma.
    Gurney H; Crowther D; Anderson H; Murphy D; Prendiville J; Ranson M; Mayor P; Swindell R; Buckley CH; Tindall VR
    Ann Oncol; 1990 Nov; 1(6):427-33. PubMed ID: 2083186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.
    Goren MP; Forastiere AA; Wright RK; Horowitz ME; Dodge RK; Kamen BA; Viar MJ; Pratt CB
    Cancer Chemother Pharmacol; 1987; 19(1):57-60. PubMed ID: 2880677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of iproplatin in metastatic breast carcinoma.
    Hortobagyi GN; Frye D; Holmes FA; Hug V; Fraschini G; Buzdar AU
    Cancer Treat Rep; 1987 Dec; 71(12):1193-6. PubMed ID: 3690529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.